Study reveals new mechanisms involved in the development of inflammatory cardiovascular diseases

A team led by LMU researchers Christian Weber and Yvonne Döring has demonstrated new mechanisms that are involved in the development of inflammatory cardiovascular diseases.

Seeing the unseen, together. 3DHISTECH and Barco at the 20th European Congress on Digital Pathology 2024

The ECDP 2024 event brings together experts, researchers, and industry leaders in the field of digital pathology. Join us from June 6th to June 8th

September 23, 2024

IL-2 Receptor-Targeted Therapy Approved for Relapsed/Refractory CTCL

The FDA approved denileukin diftitox (Lymphir), the first novel targeted systemic therapy approved for relapsed/refractory (r/r) cutaneous T-cell lymphoma (CTCL) since 2018, Citius Pharmaceuticals announced.

August 9, 2024

Oral and Emergency Contraceptive Use Fell in States With Abortion Bans

States with abortion restrictions triggered by the Dobbs decision saw a decline in prescriptions of oral contraceptives — particularly emergency contraceptives — a cohort study

June 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.